Skip to main content
. 2022 Nov 25;34(3):1005–1019. doi: 10.1007/s11224-022-02072-1

Fig. 6.

Fig. 6

Modelled interactions between SARS-CoV-2 RdRp and ponatinib, capmatinib, lonafarnib, and tedizolid phosphate. Protein–ligand interactions formed between the screen hit compounds (grey) by hydrophobic interaction (grey dotted line), salt bridges (dotted yellow line), and H-bonds (solid yellow line) with numbered residues (cyan) in the binding tunnel of RdRp are shown